Clinical Trial Update: A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for KB408 in Alpha-1 Antitrypsin Deficiency, with study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• KB408

Snippet

Sponsor: Krystal Biotech, Inc. | Conditions: Alpha 1-Antitrypsin Deficiency | Phase 1 | Status: RECRUITING